Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company and a leader in the emerging field of precision medicine and gene therapy. Through their proprietary, non-viral, nucleic acid nanoparticle platform, they are able to achieve robust gene transfer in several tissues without the immune response and limited treatment window of AAV.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 30, 2008 | Grant | — | 1 | Ohio Department of Development | — | Detail |
Nov 20, 2002 | Series Unknown | $2M | 1 | Veron International | — | Detail |
Jan 1, 1999 | Series Unknown | $4.60M | 1 | Biotechnology Development Fund VI, L.P. | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ohio Department of Development | Yes | Grant |
Veron International | Yes | Series Unknown |
Biotechnology Development Fund VI, L.P. | Yes | Series Unknown |